Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Stereotactic Body Radiation Therapy
98%
Overall Survival
81%
Neoplasm
51%
Radiation Therapy
44%
Lung Cancer
40%
Lung
26%
Non-Small Cell Lung Cancer
21%
Recurrent Disease
20%
Quality of Life
18%
Lung Tumor
18%
Small Cell Lung Cancer
18%
Geriatric Assessment
18%
Geriatrics
18%
Thrombin
18%
Diseases
16%
Hazard Ratio
13%
Survival Rate
13%
Malignant Neoplasm
13%
Proportional Hazards Model
12%
Thrombocyte Aggregation
12%
Chemoradiotherapy
10%
Comorbidity
10%
Subgroup Analysis
10%
Trachea
10%
Bleeding
9%
Retrospective Study
9%
Hand Grip
9%
Hemispheric Dominance
9%
Pooled Analysis
9%
COVID-19
9%
Cross Sectional Study
9%
Telehealth
9%
Magnetic Resonance Imaging of the Brain
9%
Radiosurgery
9%
Stereotactic Radiosurgery
9%
Radiation Oncology
9%
Chronic Obstructive Pulmonary Disease
9%
Stereotactic Radiotherapy
9%
Rib Fracture
9%
Coronary Artery Calcium
9%
Main Bronchus
9%
Cancer Registry
6%
Cross-Validation
6%
Patient Characteristics
6%
Tracheobronchial Tree
6%
Log Rank Test
5%
Ex Vivo
5%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
98%
Non Small Cell Lung Cancer
72%
Lung Cancer
63%
Neoplasm
45%
Malignant Neoplasm
42%
Recurrent Disease
23%
Comorbidity
21%
Small Cell Lung Cancer
18%
Survival Rate
17%
Progression Free Survival
16%
Cancer Registry
12%
Chemotherapy
10%
Chemoradiation Therapy
10%
Cross Sectional Study
9%
Retrospective Study
9%
Cross-Sectional Study
9%
Clinical Trial
9%
Thrombin
9%
Lung Tumor
9%
Messenger RNA
9%
Diseases
8%
Bleeding
7%
Pandemic
6%
Cancer Specific Survival
6%
Glutamate Decarboxylase
6%
Cross-Validation
5%
Nursing and Health Professions
Quality of Life
27%
Stereotactic Body Radiation Therapy
18%
Overall Survival
16%
Malignant Neoplasm
15%
Non Small Cell Lung Cancer
10%
Recurrent Disease
9%
Lung Cancer
9%
Geriatric Assessment
9%
Telehealth
9%
Survival Rate
9%
Cross-Sectional Study
9%
Radiotherapy
9%
Pandemic
6%
University Hospital
5%
